RecruitingNot ApplicableNCT07214675

The Edison System for Treatment of Benign Prostatic Hyperplasia (BPH) Using Histotripsy

Sponsor

HistoSonics, Inc.

Enrollment

80 participants

Start Date

Mar 20, 2026

Study Type

INTERVENTIONAL

Conditions

Benign Prostatic Hyperplasia

Summary

The purpose of this trial is to evaluate the safety of histotripsy using the HistoSonics Edison System for treatment of BPH.

Eligibility

Sex: MALEMin Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called HistoSonics Edison System for people with benign prostatic hyperplasia. The study is currently recruiting participants at 1 location. People eligible for this study include men aged 50 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHistoSonics Edison System

The HistoSonics Edison System is intended for the non-invasive mechanical destruction of prostate tissue for the treatment of BPH using histotripsy, a non-thermal, mechanical process of focused ultrasound.